A case of fluoxetine induced dyskinesia in an elderly woman with previous use of low dose haloperidol is described. In contrast to neuroleptic induced tardive dyskinesia it was characterised by a rapid onset after commencing fluoxetine and rapid resolution on cessation. In the case discussion we describe other cases of fluoxetine induced extrapyramidal syndromes and possible mechanisms.
References
1.
KoenigHGBlazesDG.Epidemiology of geriatric affective disorders. Clinics in Geriatric Medicine1992; 8:235–251.
2.
BudmanCLBraunRD.Persistent dyskinesia in a patient receiving fluoxetine. American Journal of Psychiatry1991; 148:10.
3.
SteinMH.Tardive dyskinesia in a patient taking haloperidol and fluoxetine. American Journal of Psychiatry1991; 148:638.
4.
BurkeRE.Tardive dyskinesia: current clinical issues. Neurology1984; 34:1348–1353.
5.
KaneJMSmithJM.Tardive dyskinesia: prevalence and risk factors, 1959–1979. Archives of General Psychiatry1982; 39:473–481.
6.
SmithJMBaldessariniRJ.Changes in prevalence, severity and recovery in tardive dyskinesia with age. Archives of General Psychiatry1980; 37:1368–1373.
7.
JesteDVWyattRJ.Changing epidemiology of tardive dyskinesia: an overview. American Journal of Psychiatry1981; 138:297–309.
8.
MunetzMRBenjaminS.How to examine patients using the Abnormal Involuntary Movement Scale. Hospital and Community Psychiatry1988; 39:1172–1177.
9.
MooreDCBowersMB.Identification of a subgroup of tardive dyskinesia patients by pharmacological probes. American Journal of Psychiatry1980; 137:1202–1205.
StahlSMDavidKLBergerPA.The neuropharpharmacology of tardive dyskinesia, spontaneous dyskinesia and other dystonias. Journal of Clinical Psychopharmacology1982; 2:321–343.
12.
BaldessariniRJTarsyD.Mechanisms underlying tardive dyskinesia. In: YahrMD, ed. The basal ganglia. New York: Raven Press, 1976:433–452.
13.
BouchardRHPourcherEVincentP.Fluoxetine and extrapyramidal side effects. American Journal of Psychiatry1989; 146:1352–1353.
14.
BrodTM.Fluoxetine and extrapyramidal side effects. American Journal of Psychiatry1989; 146:1353.
15.
LipinskiJFMallyaGZimmermanPPopeHG.Fluoxetine-in-duced akathisia: clinical and theroretical implications. Journal of Clinical Psychiatry1989; 50:339–342.
16.
FalconBALiebowitzMR.Fluoxetine and extrapyramidal symptoms in CNS lupus. Journal of Clinical Psychopharmacology1991; 11:147–148.
17.
TateJL.Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine. American Journal of Psychiatry1989; 146:399–400.
18.
MeltzerHYYoungMMetzJFangVSSchyvePMAroraRC.Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. Journal of Neural Transmission1979; 45:165–175.
19.
BaldessariniRJMarshE.Fluoxetine and side effects. Archives of General Psychiatry1990; 47:191–192.
20.
KozellLSandykRWagnerGCFisherH.The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. Life Sciences1987; 41:1739–1744.
21.
FibigerHCLloydKG.Neurobiological substracts of tardive dyskinesia: the GABA hypothesis. Trends in Neuroscience. 1984; 7: 462–464.
